References
Referencesarepublicationsthatsupporttheproducts'biologicalactivity.
Rao&Mishra(1998)AntihepatotoxicactivityofmonomethylfumarateisolatedfromFumariaindica.J.Ethnopharmacol.60207PMID:9613834
Scannevinetal(2012)Fumaratespromotecytoprotectionofcentralnervoussystemcellsagainstoxidativestressviathenuclearfactor(erythroid-derived2)-like2pathway.J.Pharmacol.Exp.Ther.341274PMID:22267202
Hansonetal(2010)Nicotinicacid-andmonomethylfumarate-inducedflushinginvolvesGPR109AexpressedbykeratinocytesandCOX-2-dependentprostanoidformationinmice.J.Clin.Invest.1202910PMID:20664170
Tangetal(2008)Thepsoriasisdurgmonomethylfumarateisapotentnicotinicreceptoragonist.Biochem.Biophys.Res.Commun.375562PMID:18722346
Sciacovellietal(2016)Fumarateisanepigeneticmodifierthatelicitsepithelial-to-mesenchymaltransitionNature537544PMID:27580029
Keywords:MMF,supplier,monomethylfumarate,nuclear,factor,erythroid,derived,like,2,pathway,Nrf2,activators,GPR109A,niacin,nicotinic,acid,receptors,agonists,metabolite,dimethylfumarate,DMF,mono-Methyl,fumarate,Antioxidants,Hydroxycarboxylic,Acid,Receptors,Nrf2,Antioxidants,TocrisBioscience